肌素-囊素C比的预测值,用于死亡率和技术失败在尿腹膜透析患者
Zhihong Zhang1, Tingting Zhou1, Man Zhang1
1National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China.
Renal failure
|January 2, 2025
概括
肌素与囊素C (Cr/CysC) 的比率可以预测尿液周周透透析 (PD) 患者的死亡率和技术失败. 这一发现凸显了Cr/CysC作为PD患者的有价值的预后标志物.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物标志物 生物标志物
- 功能 功能 功能
背景情况:
- 血清肌素和囊素C是已确立的功能标志物.
- 肌素与囊素C (Cr/CysC) 的比率与临床结果相关.
- 腹腔透析 (PD) 的尿病患者依靠溶液清除才能生存.
研究的目的:
- 调查Cr/CysC比率对所有原因死亡率的预测值.
- 评估Cr/CysC比率在无尿性PD患者中预测技术失败的能力.
主要方法:
- 从2014年到2023年,研究了224名无尿性PD患者的队列.
- 使用并发的血清肌素和囊素C水平计算了Cr/CysC比.
- 考克斯回归和竞争风险分析被用来评估结果.
主要成果:
- 在队列中,平均Cr/CysC比为1.85±0.56.
- 较高的Cr/CysC比率与所有原因死亡率 (HR = 0.330) 和技术失败 (HR = 0.440) 的风险降低显著相关.
- 经过对混因素和竞争风险进行调整后,这些关联仍然很重要.
结论:
- 基线Cr/CysC比率是无尿性PD患者死亡率和技术失败的独立预测指标.
- 这一比率为治疗腹膜透析患者提供了有价值的预后信息.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
30
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
30
Dialysis
225
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
225
Renal Clearance
348
The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
348
Renal Failure: Dose Adjustments
34
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
34


